JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Get Free Report) was the recipient of a large growth in short interest in July. As of July 31st, there was short interest totaling 13,260 shares, a growth of 596.1% from the July 15th total of 1,905 shares. Approximately 0.2% of the shares of the company are sold short. Based on an average trading volume of 2,556 shares, the short-interest ratio is currently 5.2 days.
JLens 500 Jewish Advocacy U.S. ETF Stock Performance
Shares of NYSEARCA:TOV traded up $0.17 on Thursday, hitting $32.75. The company’s stock had a trading volume of 335 shares, compared to its average volume of 11,066. JLens 500 Jewish Advocacy U.S. ETF has a 12 month low of $26.52 and a 12 month high of $32.75. The company has a market capitalization of $275.10 million, a price-to-earnings ratio of 25.69 and a beta of 1.03. The stock’s 50-day moving average is $31.52 and its two-hundred day moving average is $30.09.
Institutional Investors Weigh In On JLens 500 Jewish Advocacy U.S. ETF
Institutional investors have recently bought and sold shares of the stock. JPMorgan Chase & Co. acquired a new position in JLens 500 Jewish Advocacy U.S. ETF during the 3rd quarter valued at about $25,000. Bank of New York Mellon Corp lifted its stake in shares of JLens 500 Jewish Advocacy U.S. ETF by 66.7% in the 1st quarter. Bank of New York Mellon Corp now owns 71,189 shares of the company’s stock worth $1,946,000 after acquiring an additional 28,496 shares during the period. Finally, Captrust Financial Advisors acquired a new stake in shares of JLens 500 Jewish Advocacy U.S. ETF in the 2nd quarter worth approximately $6,038,000.
JLens 500 Jewish Advocacy U.S. ETF Company Profile
The JLens 500 Jewish Advocacy U.S. ETF (TOV) is an exchange-traded fund that is based on the JLens 500 Jewish Advocacy U.S. index. The fund tracks an index of large-cap US stocks while employing a methodology that seeks to align stock selection and weighting with Jewish value pillars. TOV was launched on Feb 26, 2025 and is issued by JLens.
Featured Stories
- Five stocks we like better than JLens 500 Jewish Advocacy U.S. ETF
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
- Lumentum Just Delivered the AI Growth Investors Wanted
- Ryman Checks Into a $1.38B Hospitality Upgrade
Receive News & Ratings for JLens 500 Jewish Advocacy U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JLens 500 Jewish Advocacy U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.
